Xcell Biosciences
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $39M
Investors
- 7
About Xcell Biosciences
Xcell Biosciences, Inc.Founded in 2012, Xcell Biosciences, Inc. operates out of San Francisco, US, specializing in cell therapy manufacturing. The company was established by Brian Feth, who has a history of founding other ventures.Xcell Biosciences specializes in advanced cell therapy manufacturing, primarily through its innovative product offerings, which include the AVATAR series—AVATAR Foundry, AVATAR Odyssey, and AVATAR AI. The AVATAR Foundry serves as a scalable expansion platform aimed at producing cell therapies that can operate effectively within tumor microenvironments, enhancing the metabolic fitness of these therapies. AVATAR Odyssey is designed to improve cellular transduction processes, while AVATAR AI focuses on measuring the potency of cell therapy products. These offerings primarily target research institutions and biotechnology companies engaged in developing cancer immunotherapies and other cell-based treatments.Xcell Biosciences generates revenue through a business-to-business model, primarily engaging with research institutions and biotechnology firms that require specialized cell therapy manufacturing solutions. Transactions typically involve direct partnerships where clients utilize Xcell's AVATAR products in their research and development efforts, creating ongoing relationships centered around product supply and support. Specific pricing structures are established based on the nature of the services rendered, including potential subscription models for ongoing access to the AVATAR series and one-time fees for specific projects or product deployments.In December 2024, Xcell Biosciences, Inc. The company aims to enhance its product offerings by introducing updated versions of the AVATAR series and seeks to penetrate additional markets in Europe and Asia-Pacific by 2025.
Who invested in Xcell Biosciences
7 investors across 3 rounds
See all investors in Xcell Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xcell Biosciences
Who invested in Xcell Biosciences?
Xcell Biosciences has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xcell Biosciences raised?
Xcell Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Xcell Biosciences last raise money?
Xcell Biosciences's most recent round on record is a Series B, in Jan 2022.
What does Xcell Biosciences do?
Xcell Biosciences is a software company.
Where is Xcell Biosciences headquartered?
Xcell Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like Xcell Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Xcell Biosciences's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Xcell Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.